Back to Agenda

Neuromodulator Longevity and Migration Clinical 2

This session will provide a comprehensive analysis of the five FDA-approved neuromodulators in the United States, examining their distinct characteristics and clinical implications. Through a comparative lens, attendees will gain valuable insights into the longevity of each neuromodulator, drawing upon robust clinical studies. Furthermore, the session will explore the critical relationship between dilution and migration, offering practical strategies to mitigate common complications associated with migration in clinical practice. Don't miss this opportunity to enhance your expertise and refine your approach to neuromodulator administration.